ASH Young Scholar Awards
ASH members may nominate qualified young investigators for the ASH Young Scholar Award. The Young Scholar Award recognizes the achievements of outstanding young investigators in the field of hypertension.
The Young Scholar Award will be presented during the Annual Scientific Meeting and Exposition of the American Society of Hypertension, Inc.
One award will be given, with $3,000 as a personal award, and $3,000 toward laboratory expenses ($6,000 total for the award). The awardee will also be asked to give a brief lecture presenting the research for which the award was given at the ASH Annual Scientific Meeting.
To qualify for the award, candidates must have received an advance professional degree within the last 15 years and be currently active in research in hypertension or related cardiovascular diseases. Only applicants from North America are considered.
Who wish to have their candidates nominated for an award must be current ASH members and provide the following information:
||Complete name, address, phone, and fax numbers, and email of the nominee.
||A signed letter of recommendation from the sponsor with a description of the candidate's achievements.
Should supply 8 copies of the following:
||Current curriculum vitae
||2 original publications from a scientific journal
For more information, please contact:
Ashley Buron, Program Coordinator
American Society of Hypertension
45 Main Street, suite #712
Brooklyn, NY 11201
The American Society of Hypertension is pleased to announce the recipient of the ASH 2014 Young Scholar Award:
Justin L. Grobe, PhD
The 2014 Awards were presented during the ASH Twenty-Ninth Annual Scientific Meeting during the Awards Plenary Session, held on Monday, May 19, 2014.
Justin L. Grobe, PhD
ASH Young Scholar Award Recipient
Justin L. Grobe, PhD, is an Assistant Professor of Pharmacology at the University of Iowa's Carver College of Medicine. He received his PhD in Pharmacodynamics from the University of Florida's College of Pharmacy in 2006, and performed postdoctoral work in Internal Medicine at the
University of Iowa. His ongoing research focuses on two distinct areas; the control of metabolic and cardiovascular function by the brain renin-angiotensin system, and the very early-pregnancy events that precipitate the development of the late-pregnancy cardiovascular disorder, preeclampsia.
Justin's work in these areas is currently supported through grants from the National Heart Lung and Blood Institute (both a K99/R00 award, and participation in a Program Project Grant), the American Heart Association, and the American Diabetes Association. These latest awards contribute to a full twenty years of uninterrupted extramural fellowship and research support. He has authored or coauthored thirty-two manuscripts published in distinguished journals including Cell Metabolism, Molecular Metabolism, Physiology, and Hypertension, and has several additional manuscripts currently in preparation or review. Justin's group has also recently documented the development of superior technologies to assess metabolic rate control in mice, and he is a co-inventor on multiple new patents describing novel extremely-early pregnancy diagnostic biomarker tests and potential pharmacological therapeutic approaches for preeclampsia.